MedTrace Logo

Treatment Resistant Depression in America Latina

NCT03207282 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1539

Last updated 2025-04-27

No results posted yet for this study

Summary

The purpose of this study is to estimate the prevalence of Treatment Resistant Depression (TRD) among Major Depressive Disorder (MDD) participants being treated in a psychiatry reference site (example, clinic, ambulatory, hospital, day-hospital) in 4 Latin American countries: Argentina, Brazil, Colombia and Mexico; and to evaluate all and depression-related healthcare resource utilization in TRD participants.

Conditions

  • Depressive Disorder, Treatment-Resistant

Sponsors & Collaborators

  • Janssen-Cilag, S.A.

    lead INDUSTRY

Principal Investigators

  • Jannsen Cilag S.A. Clinical Trial · Jannsen Cilag S.A.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-27
Primary Completion
2019-11-25
Completion
2019-11-25

Countries

  • Argentina
  • Brazil
  • Colombia
  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03207282 on ClinicalTrials.gov